升陷汤治疗心力衰竭的研究进展
Research Progress on Shengxian Decoction in the Treatment of Heart Failure
摘要: 心力衰竭是一种多因素驱动、累及心血管系统的慢性进展性疾病，具有高死亡率、高再住院率以及预后不良的特点，重症患者心肌收缩功能严重受损，甚至可能引发恶性心律失常或猝死。升陷汤出自张锡纯《医学衷中参西录》，是中医临床上用于治疗大气下陷型心力衰竭的经典方剂，具有益气升陷、举元固脱之效。本方体现了中医整体调节、多靶点干预、标本同治的优势，能有效改善心功能，缓解心悸气短、乏力水肿等核心症状，降低再住院风险，提高患者的生活质量。这篇文章综述升陷汤治疗心力衰竭的基础研究与临床应用进展，为临床治疗提供新的依据与思路。
Abstract: Heart failure is a chronic progressive disease driven by multiple factors that affects the cardiovascular system. It is characterized by high mortality and readmission rates, as well as a poor prognosis. In severe cases, myocardial contractile function is significantly impaired, potentially leading to malignant arrhythmias or sudden death. Shengxian Decoction, originating from Xichun Zhang’s Records of Traditional Chinese and Western Medicine in Combination, is a classic formula used in clinical practice in Traditional Chinese Medicine for treating heart failure characterized by the collapse of the body’s vital energy (Daqi Xianxia). It functions to replenish Qi, elevate the collapsed energy, and stabilize collapse. This formula embodies the advantages of Traditional Chinese Medicine, including holistic regulation, multi-target intervention, and simultaneous treatment of both the root cause and symptoms. It effectively improves cardiac function, alleviates core symptoms such as palpitations, shortness of breath, fatigue, and edema, reduces the risk of readmission, and enhances patients’ quality of life. This article reviews the progress in basic research and clinical application of Shengxian Decoction in the treatment of heart failure, providing new evidence and insights for clinical practice.
文章引用：陈菲尔, 李雪萍. 升陷汤治疗心力衰竭的研究进展[J]. 临床医学进展, 2026, 16(2): 3341-3348. https://doi.org/10.12677/acm.2026.162748

参考文献

[1] Savarese, G., Becher, P.M., Lund, L.H., Seferovic, P., Rosano, G.M.C. and Coats, A.J.S. (2023) Global Burden of Heart Failure: A Com-Prehensive and Updated Review of Epidemiology. Cardiovascular Research, 118, 3272-3287.
[2] Kumar, S. and Psotka, M.A. (2023) Heart Failure without a Reduced Ejection Fraction. The American Journal of Managed Care, 29, S187-S194.
[3] Rees, O.L., Wheen, P. and Anderson, L.J. (2023) Updates in Heart Failure. Clinical Medicine, 23, 432-436. [Google Scholar] [CrossRef] [PubMed]
[4] 赵国元, 毛静远, 毕颖斐, 等. 心力衰竭患者气阴两虚和阳气亏虚证客观特征分析[J]. 中西医结合心脑血管病杂志, 2015, 13(11): 1249-1251.
[5] 王明珠, 符德玉, 姚磊, 等. 基于网络药理学研究升陷汤治疗心力衰竭的作用机制[J]. 中成药, 2021, 43(1): 228-234.
[6] Zhang, H. and Dhalla, N.S. (2024) The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease. International Journal of Molecular Sciences, 25, Article 1082. [Google Scholar] [CrossRef] [PubMed]
[7] Fedacko, J., Singh, R.B., Gupta, A., Hristova, K., Toda, E., Kumar, A., et al. (2014) INFL Ammatory Mediators in Chronic Heart Failure in North India. Acta Cardiologica, 69, 391-398. [Google Scholar] [CrossRef] [PubMed]
[8] Ali, A., Rashid, M.A., Huang, Q.Y. and Lei, C. (2017) Influence of UV-A Radiation on Oxidative Stress and Antioxidant Enzymes in Mythimna separata (Lepidoptera: Noctuidae). Environmental Science and Pollution Research, 24, 8392-8398. [Google Scholar] [CrossRef] [PubMed]
[9] 高卉, 杨泽祺, 高凡, 等. 升陷汤对慢性心力衰竭大鼠心功能及心肌线粒体能量代谢影响[J]. 中国中西医结合杂志, 2025, 45(5): 593-602.
[10] 刘聪, 阚建英, 王作顺. 加味升陷汤对气虚血瘀证心力衰竭病人心室重构及炎性因子的影响[J]. 中西医结合心脑血管病杂志, 2025, 23(6): 886-889.
[11] Yu, H., Lin, L., Zhang, Z., Zhang, H. and Hu, H. (2020) Targeting NF-κB Pathway for the Therapy of Diseases: Mechanism and Clinical Study. Signal Transduction and Targeted Therapy, 5, Article No. 209. [Google Scholar] [CrossRef] [PubMed]
[12] 贾倩芳, 李习婉. 基于网络药理学探讨升陷汤治疗慢性心力衰竭的作用机制[J]. 河南医学研究, 2024, 33(3): 385-392.
[13] 李尊江, 于潇潇, 王冬梅, 等. 基于网络药理学研究心宝丸治疗慢性心力衰竭的作用机制. 中药新药与临床药理, 2018, 29(6): 768-774.
[14] 曲艺, 但文超, 刘金垒, 等. 基于网络药理学的升陷汤治疗心力衰竭的作用机制研究[J]. 世界科学技术-中医药现代化, 2020, 22(10): 3583-3593.
[15] Tan, L., Xiong, D., Zhang, H., Xiao, S., Yi, R. and Wu, J. (2023) ETS2 Promotes Cardiomyocyte Apoptosis and Autophagy in Heart Failure by Regulating lncRNA TUG1/miR-129-5p/ATG7. The FASEB Journal, 37, e22937. [Google Scholar] [CrossRef] [PubMed]
[16] Yin, J., Hu, L., Han, X., Chen, L., Yu, L. and Lu, Y. (2023) MiR-18a-5p Aggravates Homocysteine-Induced Myocardial Injury via Autophagy. Journal of Central South University. Medical Sciences Journal, 48, 24-33.
[17] 谷雪军, 邹文庆, 邹佳辰. 加味升陷汤联合常规治疗对慢性心力衰竭患者心功能及血清同型半胱氨酸高敏肌钙蛋白T影响[J]. 中医药临床杂志, 2024, 36(6): 1124-1128.
[18] Boadi, W.Y., Amartey, P.K. and Lo, A. (2015) Effect of Quercetin, Genistein and Kaempferol on Glutathione and Glutathione-Redox Cycle Enzymes in 3T3-L1 Preadipocytes. Drug and Chemical Toxicology, 39, 239-247. [Google Scholar] [CrossRef] [PubMed]
[19] 巩亮, 胡威, 王晓春, 等. 异鼠李素对多柔比星诱导的心肌细胞自噬和凋亡的影响[J]. 中国临床药理学杂志, 2021, 37(4): 385-388.
[20] 赵小双, 杨海波, 赵荫涛, 等. 山柰酚对大鼠心肌细胞H9c2凋亡的影响[J]. 郑州大学学报(医学版), 2019, 54(1): 106-110.
[21] Kapustian, L., Kroupskaya, I., Rozhko, O., Bobyk, V., Ryabenko, D. and Sidorik, L. (2014) Akt1 Expression and Activity at Different Stages in Experimental Heart Failure. Pathophysiology, 21, 147-151. [Google Scholar] [CrossRef] [PubMed]
[22] Liu, Y., Yuan, G., Nan, H., Cen, J., Zhu, X., Zhou, Y., et al. (2021) Selenium Nanoparticles with Various Morphology for Antiangiogenesis through BFGF-Mediated P13K/AKT Signaling Pathways. Nanotechnology, 32, Article ID: 485102. [Google Scholar] [CrossRef] [PubMed]
[23] 金晓玲, 陈岚, 张凤, 等. 升陷汤及单味药材水提物对缺氧/复氧致心肌损伤的保护作用[J]. 药学实践杂志, 2021, 39(3): 240-244.
[24] Sun, Q., Karwi, Q.G., Wong, N. and Lopaschuk, G.D. (2024) Advances in Myocardial Energy Metabolism: Metabolic Remodelling in Heart Failure and Beyond. Cardiovascular Research, 120, 1996-2016. [Google Scholar] [CrossRef] [PubMed]
[25] Houten, S.M., Wanders, R.J.A. and Ranea-Robles, P. (2020) Metabolic Interactions between Peroxisomes and Mitochondria with a Special Focus on Acylcarnitine Metabolism. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1866, Article ID: 165720. [Google Scholar] [CrossRef] [PubMed]
[26] Vercellino, I. and Sazanov, L.A. (2021) The Assembly, Regulation and Function of the Mitochondrial Respiratory Chain. Nature Reviews Molecular Cell Biology, 23, 141-161. [Google Scholar] [CrossRef] [PubMed]
[27] Halling, J.F. and Pilegaard, H. (2020) Pgc-1α-mediated Regulation of Mitochondrial Function and Physiological Implications. Applied Physiology, Nutrition, and Metabolism, 45, 927-936. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, Z., Han, Y., Gao, F., Tian, J., Bai, R., Guo, Q., et al. (2023) Shengxian Decoction Protects against Chronic Heart Failure in a Rat Model via Energy Regulation Mechanisms. BMC Complementary Medicine and Therapies, 23, Article No. 200. [Google Scholar] [CrossRef] [PubMed]
[29] Herzig, S. and Shaw, R.J. (2017) AMPK: Guardian of Metabolism and Mitochondrial Homeostasis. Nature Reviews Molecular Cell Biology, 19, 121-135. [Google Scholar] [CrossRef] [PubMed]
[30] 韩杨杨. 升陷汤对慢性心力衰竭大鼠心肌线粒体能量代谢的调节及机制探讨[D]: [硕士学位论文]. 石家庄: 河北中医药大学, 2023.
[31] 王天宝, 马冬璞, 刘毓, 等. 黄芪甲苷对急性心力衰竭大鼠心肌线粒体能量代谢的影响[J]. 广州中医药大学学报, 2022, 39(4): 884-891.
[32] 吕芳, 李卫萍, 田朝霞, 等. 木犀草素通过调控AMPK/SIRT3通路改善慢性心力衰竭大鼠心脏功能及心肌纤维化的研究[J]. 免疫学杂志, 2022, 38(5): 407-415.
[33] 郑艳, 刘艳辉, 胡杰, 等. 犀草素对心力衰竭大鼠心室重构的改善和对PI3K/Akt/mTOR信号通路的调控作用[J]. 中国心血管杂志, 2021, 26(2): 169-173.
[34] 李晓莹, 李思琦, 付天骄, 等. 基于网络药理学分析升陷汤治疗射血分数保留型心力衰竭的作用机制[J]. 中国当代医药, 2023, 30(36): 11-14+21.
[35] Warbrick, I. and Rabkin, S.W. (2019) Hypoxia‐Inducible Factor 1‐α (HIF‐1α) as a Factor Mediating the Relationship between Obesity and Heart Failure with Preserved Ejection Fraction. Obesity Reviews, 20, 701-712. [Google Scholar] [CrossRef] [PubMed]
[36] 陈阳, 张彦周. 白细胞介素-17(A)在心室重构中的作用[J]. 临床心血管病杂志, 2017, 33(5): 487-489.
[37] 郭志英, 李玉锋, 徐浩. 徐浩教授应用升陷汤治疗慢性心衰临床经验[J]. 中国中医急症, 2024, 33(2): 321-323+372.
[38] 王素芹, 张曙光, 李鹤, 等. 汪再舫运用升陷汤化裁治疗心系疾病验案3则[J]. 江苏中医药, 2023, 55(10): 55-57.
[39] 南希, 邓悦. 邓悦教授应用升陷汤加味治疗慢性心力衰竭合并痛风1例[J]. 中西医结合心脑血管病杂志, 2022, 20(15): 2873-2874.
[40] 刘东梅. 慢性心力衰竭运用加味升陷汤协同沙库巴曲缬沙坦钠治疗的临床疗效观察[J]. 中国医药指南, 2025, 23(16): 29-31.
[41] 谢航, 李东东. “益气升陷汤”联合常规西药治疗气虚血瘀型慢性心力衰竭42例临床研究[J]. 江苏中医药, 2024, 56(4): 38-41.
[42] 田志广. 加味升陷汤辅治慢性心力衰竭临床观察[J]. 实用中医药杂志, 2024, 40(2): 254-256.
[43] 张超, 杜宗礼, 李正兰, 等. 加味升陷汤对气虚水停型慢性心力衰竭患者的临床疗效[J]. 中成药, 2023, 45(2): 690-692.
[44] 李虹霓. 升陷汤加味合艾灸治疗老年慢性心衰气虚血瘀证的疗效观察[D]: [硕士学位论文]. 昆明: 云南中医药大学, 2024.
[45] 邹晓琪, 周狄, 陈伶利, 等. 升陷汤联合隔物灸治疗慢性心力衰竭临床观察[J]. 山西中医, 2023, 39(1): 12-14.
[46] 张玉焕, 李争, 刘薇. 升陷汤隔药灸治疗气虚血瘀型慢性心力衰竭的疗效及对患者血清NT-proBNP、炎症因子的影响[J]. 中医药导报, 2021, 27(2): 63-67.

为你推荐